Experience of Frosinone Simt in the management of patients treated with Daratumumab
Authors: D’Amico C. et al.
Date: 2019
Scope of interest: Transfusion Medicine
06 99 39
Recup number
You may also be interested in:
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors
Authors: Benedetta Stefanini et al
Date: 22 Nov 2023
Scope of interest: hepatological
Read details
Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2.
Authors: Fedele G, Palmieri A, Damiano C, Di Lonardo A, Leone P, Schiavoni I, Trevisan C, Abbatecola AM, Cafariello C, Malara A, Minchella P, Panduri G, Antonelli Incalzi R, Palamara AT, Stefanelli P, Onder G; GeroCovid Vax Study Group.
Date: 2022
Scope of interest: ageing, geriatrics
Read details
Presence of the groupematic phenotype fy (a-;b-) in a population of blood donors: ®experience of the SIMT of the Policlinico Di Tor Vergata (PTV) Rome”
Authors: De Simone M.L., Dominici L., Blefari T., Del Proposto G., Cordero V., Costantino L., Docimo F., Guiducci G., Palazzo G., De Masi A., Antonelli M., Adorno G.
Date: 2014
Scope of interest: Clinical pathology
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
